| Literature DB >> 31178402 |
Xinghao Zhang1, Patrick S McGrath1, Joseph Salomone2, Mohamed Rahal3, Heather A McCauley1, Jamie Schweitzer1, Rhett Kovall4, Brian Gebelein2, James M Wells5.
Abstract
Neurogenin3 (NEUROG3) is required for endocrine lineage formation of the pancreas and intestine. Patients with NEUROG3 mutations are born with congenital malabsorptive diarrhea due to complete loss of enteroendocrine cells, whereas endocrine pancreas development varies in an allele-specific manner. These findings suggest a context-dependent requirement for NEUROG3 in pancreas versus intestine. We utilized human tissue differentiated from NEUROG3-/- pluripotent stem cells for functional analyses. Most disease-associated alleles had hypomorphic or null phenotype in both tissues, whereas the S171fsX68 mutation had reduced activity in the pancreas but largely null in the intestine. Biochemical studies revealed NEUROG3 variants have distinct molecular defects with altered protein stability, DNA binding, and gene transcription. Moreover, NEUROG3 was highly unstable in the intestinal epithelium, explaining the enhanced sensitivity of intestinal defects relative to the pancreas. These studies emphasize that studies of human mutations in the endogenous tissue context may be required to assess structure-function relationships.Entities:
Keywords: Neurogenin3; diabetes; digestive disease; disease mechanism; enteroendocrine; human organoids; intestine; pancreas; pluripotent stem cells
Mesh:
Substances:
Year: 2019 PMID: 31178402 PMCID: PMC7082840 DOI: 10.1016/j.devcel.2019.05.017
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270